Tianjin Pharmaceutical da Ren Tang Group Ltd 2021 Annual Report
Company: Tianjin Pharmaceutical da Ren Tang Group Ltd
Sector: Manufacturing
Country: China
Year: 2021
Type: Annual Report
Pages: 212
The report records FY2021 Group revenue of approximately RMB 6,908 million and describes continued emphasis on product quality and safety, research and development, operational efficiency and corporate governance. It assigns a Sustainability task force to oversee sustainability reporting and identifies energy, water, emissions, effluents and waste, occupational health and safety, and diversity as relevant topics. The sustainability disclosure is brief and refers readers to a separate 2020 Sustainability Report for further information.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.